Suven Life Sciences Ltd
NSE:SUVEN

Watchlist Manager
Suven Life Sciences Ltd Logo
Suven Life Sciences Ltd
NSE:SUVEN
Watchlist
Price: 117.47 INR -0.53% Market Closed
Market Cap: 25.6B INR
Have any thoughts about
Suven Life Sciences Ltd?
Write Note

Intrinsic Value

SUVEN's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one SUVEN stock under the Base Case scenario is 2.1 INR. Compared to the current market price of 117.47 INR, Suven Life Sciences Ltd is Overvalued by 98%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SUVEN Intrinsic Value
2.1 INR
Overvaluation 98%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Suven Life Sciences Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SUVEN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SUVEN?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Suven Life Sciences Ltd

Provide an overview of the primary business activities
of Suven Life Sciences Ltd.

What unique competitive advantages
does Suven Life Sciences Ltd hold over its rivals?

What risks and challenges
does Suven Life Sciences Ltd face in the near future?

Has there been any significant insider trading activity
in Suven Life Sciences Ltd recently?

Summarize the latest earnings call
of Suven Life Sciences Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Suven Life Sciences Ltd.

Provide P/S
for Suven Life Sciences Ltd.

Provide P/E
for Suven Life Sciences Ltd.

Provide P/OCF
for Suven Life Sciences Ltd.

Provide P/FCFE
for Suven Life Sciences Ltd.

Provide P/B
for Suven Life Sciences Ltd.

Provide EV/S
for Suven Life Sciences Ltd.

Provide EV/GP
for Suven Life Sciences Ltd.

Provide EV/EBITDA
for Suven Life Sciences Ltd.

Provide EV/EBIT
for Suven Life Sciences Ltd.

Provide EV/OCF
for Suven Life Sciences Ltd.

Provide EV/FCFF
for Suven Life Sciences Ltd.

Provide EV/IC
for Suven Life Sciences Ltd.

Show me price targets
for Suven Life Sciences Ltd made by professional analysts.

What are the Revenue projections
for Suven Life Sciences Ltd?

How accurate were the past Revenue estimates
for Suven Life Sciences Ltd?

What are the Net Income projections
for Suven Life Sciences Ltd?

How accurate were the past Net Income estimates
for Suven Life Sciences Ltd?

What are the EPS projections
for Suven Life Sciences Ltd?

How accurate were the past EPS estimates
for Suven Life Sciences Ltd?

What are the EBIT projections
for Suven Life Sciences Ltd?

How accurate were the past EBIT estimates
for Suven Life Sciences Ltd?

Compare the revenue forecasts
for Suven Life Sciences Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Suven Life Sciences Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Suven Life Sciences Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Suven Life Sciences Ltd compared to its peers.

Compare the P/E ratios
of Suven Life Sciences Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Suven Life Sciences Ltd with its peers.

Analyze the financial leverage
of Suven Life Sciences Ltd compared to its main competitors.

Show all profitability ratios
for Suven Life Sciences Ltd.

Provide ROE
for Suven Life Sciences Ltd.

Provide ROA
for Suven Life Sciences Ltd.

Provide ROIC
for Suven Life Sciences Ltd.

Provide ROCE
for Suven Life Sciences Ltd.

Provide Gross Margin
for Suven Life Sciences Ltd.

Provide Operating Margin
for Suven Life Sciences Ltd.

Provide Net Margin
for Suven Life Sciences Ltd.

Provide FCF Margin
for Suven Life Sciences Ltd.

Show all solvency ratios
for Suven Life Sciences Ltd.

Provide D/E Ratio
for Suven Life Sciences Ltd.

Provide D/A Ratio
for Suven Life Sciences Ltd.

Provide Interest Coverage Ratio
for Suven Life Sciences Ltd.

Provide Altman Z-Score Ratio
for Suven Life Sciences Ltd.

Provide Quick Ratio
for Suven Life Sciences Ltd.

Provide Current Ratio
for Suven Life Sciences Ltd.

Provide Cash Ratio
for Suven Life Sciences Ltd.

What is the historical Revenue growth
over the last 5 years for Suven Life Sciences Ltd?

What is the historical Net Income growth
over the last 5 years for Suven Life Sciences Ltd?

What is the current Free Cash Flow
of Suven Life Sciences Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Suven Life Sciences Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Suven Life Sciences Ltd

Current Assets 1.9B
Cash & Short-Term Investments 1.7B
Receivables 63.9m
Other Current Assets 136.9m
Non-Current Assets 254m
Long-Term Investments 486k
PP&E 251.6m
Intangibles 1.8m
Other Non-Current Assets 59k
Current Liabilities 179.3m
Accounts Payable 46.1m
Other Current Liabilities 133.2m
Non-Current Liabilities 13.4m
Other Non-Current Liabilities 13.4m
Efficiency

Earnings Waterfall
Suven Life Sciences Ltd

Revenue
84.1m INR
Operating Expenses
-1.7B INR
Operating Income
-1.7B INR
Other Expenses
192.9m INR
Net Income
-1.5B INR

Free Cash Flow Analysis
Suven Life Sciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

The company acknowledged the current challenging environment, particularly in the agrochemical sector, attributing difficulties to transient destocking issues. Despite a soft current quarter, management expressed confidence in a robust recovery for the '24-'25 period, bolstered by strong protection for the CDMO business and an increasing number of client inquiries.

What is Earnings Call?
Fundamental Scores

SUVEN Profitability Score
Profitability Due Diligence

Suven Life Sciences Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive 3-Years Revenue Growth
Declining ROIC
Negative 1-Year Revenue Growth
19/100
Profitability
Score

Suven Life Sciences Ltd's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

SUVEN Solvency Score
Solvency Due Diligence

Suven Life Sciences Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
69/100
Solvency
Score

Suven Life Sciences Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SUVEN Price Targets Summary
Suven Life Sciences Ltd

There are no price targets for SUVEN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SUVEN?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SUVEN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SUVEN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Suven Life Sciences Ltd Logo
Suven Life Sciences Ltd

Country

India

Industry

Life Sciences Tools & Services

Market Cap

25.6B INR

Dividend Yield

0%

Description

Suven Life Sciences Ltd. engages on discovering, developing, and commercializing novel pharmaceutical products which are used in classic therapies. The company is headquartered in Hyderabad, Telangana and currently employs 117 full-time employees. The firm is focused on discovering and developing new chemical entities (NCEs), which are central nervous system therapies for the treatment of cognitive disorders, depressive disorders, sleep disorders, psychiatric disorders, pain and inflammation, gastrointestinal motility disorders. Its research targets include serotonin 6 receptor, serotonin 4 receptor, histamine 3 receptor, Nicotinic acetylcholine (Alpha4beta2) receptor, muscarinic M1 receptor, muscarinic M4 receptor, multimodal and P2X purinoceptor 7 receptor. The company provides a range of Drug Discovery and Development Support Services (DDDSS). The firm offers research services specializing in synthetic, medicinal and analytical chemistry, in-vitro assay development and screening, drug metabolism and pharmacokinetics, toxicology and safety pharmacology, bioanalysis, and NCE formulations.

Contact

TELANGANA
Hyderabad
SDE Serene Chambers 6th Floor, Road No. 5 Avenue 7, Banjara Hills
+914023541142
www.suven.com

IPO

1995-03-06

Employees

117

Officers

CEO & Director
Mr. Venkateswarlu Jasti M.Pharm. M.S.
Whole-Time Director
Ms. Sudharani Jasti B.Sc.
Executive Chairman
Mr. Vivek Sharma CPA
Chief Financial Officer
Mr. M. Mohan Kumar C.M.A.
Company Secretary & Compliance Officer
Mr. Kundan Kumar Jha
President of US Operations
Ms. Kalyani Jasti

See Also

Discover More
What is the Intrinsic Value of one SUVEN stock?

The intrinsic value of one SUVEN stock under the Base Case scenario is 2.1 INR.

Is SUVEN stock undervalued or overvalued?

Compared to the current market price of 117.47 INR, Suven Life Sciences Ltd is Overvalued by 98%.

Back to Top